Aclaris Therapeutics OverviewAclaris Therapeutics Other Income Expense Net
Other Income/Expense Net for ACRS.
Quarterly Other Income/Expense
$2.37M
↓ 21.04% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$10.82M
↑ 2.33% YoY
Trailing 12 months ending Mar 31, 2026